Development and interpretation of a pathomics-driven ensemble model for predicting the response to immunotherapy in gastric cancer

Abstract

Our pathomics-driven ensemble model exhibited high accuracy and robustness in predicting the response to ICIs using WSIs. Therefore, it could serve as a novel and valuable tool to facilitate precision immunotherapy.